Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma-Reference-Cited by-同舟云学术

Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma

Published:2015-11-18 Issue:2 Volume:35 Page:177-186
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Kiesewetter Barbara¹,Dolak Werner²,Simonitsch-Klupp Ingrid³,Mayerhoefer Marius E.⁴,Raderer Markus¹

Affiliation:

1. Department of Internal Medicine I, Clinical Division of Oncology; Medical University of Vienna; Vienna Austria

2. Department of Internal Medicine III; Clinical Division of Gastroenterology and Hepatology; Medical University of Vienna; Vienna Austria

3. Department of Pathology; Medical University of Vienna; Vienna Austria

4. Department of Radiology; Medical University of Vienna; Vienna Austria

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference33 articles.

1. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series;Fischbach;Gut,2004

2. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome;Tsang;J Clin Oncol,2003

3. Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial;Avilés;Med Oncol,2005

4. Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial;Ferreri;J Clin Oncol,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab plus cladribine versus R-CHOP in frontline management of marginal zone lymphoma in China: a propensity-score matched multicenter study;Annals of Hematology;2022-07-20

2. Cladribine Induces ATF4 Mediated Apoptosis and Synergizes with SAHA in Diffuse Large B-Cell Lymphoma Cells;International Journal of Medical Sciences;2020

3. Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies;Multiple Sclerosis and Related Disorders;2019-01

4. Cladribine in combination with entinostat synergistically elicits anti-proliferative/anti-survival effects on multiple myeloma cells;Cell Cycle;2018-04-18

5. Cladribine/rituximab;Reactions Weekly;2017-08